Product Information
BALZIVA 28 TABLET is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $0.3471 per EA under NDC 00555903458. Its NADAC has been published 665 times since Nov 28, 2013.
FDA first approved this application on Apr 22, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00555903458
Classification
Generic
Dosage Form
KIT
Effective Date
8/19/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA076238FDA Approved
4/22/2004
TE Code
AB
On Market Since
10/16/2006
Price Statistics
The NADAC for BALZIVA 28 TABLET has been published 665 times since Nov 28, 2013, and over the history we have for it it has declined 56.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3471 per EA |
|---|---|
| All-time high | $0.9162 (Feb 11, 2015) |
| All-time low | $0.2566 (Nov 20, 2024) |
| 52-week high | $0.3471 |
| 52-week low | $0.2982 |
| Median price | $0.5155 |
| Average price | $0.5319 |
| Largest weekly change | +60.7% (May 20, 2020) |
| Weeks tracked | 665 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 39% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of BALZIVA 28 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for BALZIVA 28 TABLET, manufactured by Teva Pharmaceuticals USA Inc., is $0.3471 per EA (NDC 00555903458), effective Aug 19, 2026.
How has the price of BALZIVA 28 TABLET changed over time?
Over the history we have for it, the NADAC for BALZIVA 28 TABLET has declined 56.5%. It has been tracked across 665 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for BALZIVA 28 TABLET?
Since Nov 28, 2013, the NADAC for BALZIVA 28 TABLET has ranged from a low of $0.2566 (Nov 20, 2024) to a high of $0.9162 (Feb 11, 2015), with a median of $0.5155 per EA.
Are there cheaper alternatives to BALZIVA 28 TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, NYLIA 1-35 28 TABLET, is $0.2116 per EA — about 39% below BALZIVA 28 TABLET.
Who manufactures BALZIVA 28 TABLET?
BALZIVA 28 TABLET (NDC 00555903458) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.